Skip to main content

Advertisement

SpringerLink
Log in

Proliferation potential of spinal meningiomas

  • Original Article
  • Published:
European Spine Journal Aims and scope Submit manuscript

Abstract

Objectives: The goal of the present study was to quantitatively assess the proliferation index and progesterone receptor status of spinal versus intracranial meningiomas and to determine if these biological indicators can describe the clinical behavior of these tumors. This information could provide the spinal surgeon with important additional information concerning surgical management and follow-up recommendations for the individual patient. Methods: The study group consisted of 26 patients with spinal and 241 patients with intracranial meningiomas. Patients with atypical or anaplastic tumors as well as with neurofibromatosis type II were excluded from the study. Furthermore both groups were matched according to age, sex and resection grade (total resection according the Simpson classification). Proliferation index (Ki-67 Labelling index [LI]) and progesterone-receptor (PR) status of spinal and intracranial meningiomas were compared. Clinical charts including surgical and histological records and imaging studies were reviewed. Correlations with histological subtype, intratumoral calcifications, tumor vascularity and recurrence-free survival were analyzed. Results: Compared to the spinal group with a mean Ki-67 LI of 2.48% and a positive PR-status of 46%, proliferation rates of intracranial meningiomas were significant higher (Ki-67 LI 3.6%; P-value 0.041). No significant difference in PR status was seen (spinal PR-status 46%, P-value 0.261). Furthermore spinal meningiomas were less vascularized and showed less intratumoral calcifications. Time to recurrence was similar in spinal and intracranial tumors. Conclusion: Spinal and intracranial meningiomas differ in their proliferation activity but not in their PR status. However, despite lower proliferation rates, time to recurrence in spinal and cranial meningiomas is comparable in totally excised tumors. Further studies are needed to determine the role of other biological indicators in spinal meningioma growth and response to therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abramovich CM, Prayson RA (1998) MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors. Hum Pathol 29:1420–1427

    Article  CAS  PubMed  Google Scholar 

  2. Abramovich CM, Prayson RA (1999) Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas. Arch Pathol Lab Med 123:793–800

    CAS  PubMed  Google Scholar 

  3. Bitzer M, Opitz H, Popp J, Morgalla M, Gruber A, Heiss E, Voigt K (1998) Angiogenesis and brain oedema in intracranial meningiomas: influence of vascular endothelial growth factor. Acta Neurochir (Wien) 140:333–340

    Article  CAS  Google Scholar 

  4. Brandis A, Mirzai S, Tatagiba M, Walter GF, Samii M, Ostertag H (1993) Immunohistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and histological features. Neurosurgery 33:212–217

    CAS  PubMed  Google Scholar 

  5. Crompton MR, Gautier-Smith PC (1970) The prediction of recurrence in meningiomas. J Neurol Neurosurg Psychiatry 33:80–87

    CAS  PubMed  Google Scholar 

  6. Fewings PE, Battersby RD, Timperley WR (2000) Long-term follow up of progesterone receptor status in benign meningioma: a prognostic indicator of recurrence?. J Neurosurg 92:401–405

    CAS  PubMed  Google Scholar 

  7. Gezen F, Kahraman S, Canakci Z, Beduk A (2000) Review of 36 cases of spinal cord meningioma. Spine 25:727–731

    Article  CAS  PubMed  Google Scholar 

  8. Hossmann KA, Zulch KJ (1966) The spinal psammomatous meningiomas of women. Neurochirurgia (Stuttg) 9:106–113

    CAS  Google Scholar 

  9. Hsu DW, Efird JT, Hedley-Whyte ET (1998) MIB-1 (Ki-67) index and transforming growth factor-alpha (TGF α) immunoreactivity are significant prognostic predictors for meningiomas. Neuropathol Appl Neurobiol 24:441–452

    Article  CAS  PubMed  Google Scholar 

  10. Izycka-Swieszewska E, Rzepko R, Borowska-Lehman J, Baranowska E, Warzocha D (1999) Recurrent meningiomas–the immunohistochemical analysis of angiogenesis and cellular proliferation. Preliminary study Folia Neuropathol 37:179–184

    CAS  Google Scholar 

  11. Jallo GI, Kothbauer KF, Silvera VM, Epstein FJ (2001) Intraspinal clear cell meningioma: diagnosis and management: report of two cases. Neurosurgery 48:218–221

    Article  CAS  PubMed  Google Scholar 

  12. Jellinger K, Slowik F (1975) Histological subtypes and prognostic problems in meningiomas. J Neurol 208:279–298

    Article  CAS  PubMed  Google Scholar 

  13. Karamitopoulou E, Perentes E, Tolnay M, Probst A (1998) Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas. Hum Pathol 29:140–145

    Article  CAS  PubMed  Google Scholar 

  14. Kleihues P, Burger PC, Scheithauer B (1993) The new WHO classification of brain tumors. Brain Pathol 3:255–268

    CAS  PubMed  Google Scholar 

  15. Klekamp J, Samii M (1996) Surgical results of spinal meningiomas. Acta Neurochir Suppl (Wien) 65:77–81

    CAS  Google Scholar 

  16. Klekamp J, Samii M (1999) Surgical results for spinal meningiomas. Surg Neurol 52:552–562

    Article  CAS  PubMed  Google Scholar 

  17. Langford LA, Cooksley CS, DeMonte F (1996) Comparison of MIB-1 (Ki-67) antigen and bromodeoxyuridine proliferation indices in meningiomas. Hum Pathol 27:350–354

    Article  CAS  PubMed  Google Scholar 

  18. Matsuno A, Fujimaki T, Sasaki T, Nagashima T, Ide T, Asai A, Matsuura R, Utsunomiya H, Kirino T (1996) Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Acta Neuropathol (Berl) 91:504–510

    Article  CAS  Google Scholar 

  19. Matsuno A, Nagashima T, Matsuura R, Tanaka H, Hirakawa M, Murakami M, Tamura A, Kirino T (1996) Correlation between MIB-1 staining index and the immunoreactivity of p53 protein in recurrent and non-recurrent meningiomas. Am J Clin Pathol 106:776–781

    CAS  PubMed  Google Scholar 

  20. Meinsma-vdTuin M, Molenaar WM, Mooij JJ (2000) Spinal papillary meningioma: a case report and review of the literature. Acta Neurochir (Wien) 142:703–708

    Article  CAS  Google Scholar 

  21. Moller ML, Braendstrup O (1997) No prediction of recurrence of meningiomas by PCNA and Ki-67 immunohistochemistry. J Neurooncol 34:241–246

    Article  CAS  PubMed  Google Scholar 

  22. Nakaguchi H, Fujimaki T, Matsuno A, Matsuura R, Asai A, Suzuki I, Sasaki T, Kirino T (1999) Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry. Cancer 85:2249–2254

    Article  CAS  PubMed  Google Scholar 

  23. Nakasu S, Li DH, Okabe H, Nakajima M, Matsuda M (2001) Significance of MIB-1 staining indices in meningiomas: comparison of two counting methods. Am J Surg Pathol 25:472–478

    Article  CAS  PubMed  Google Scholar 

  24. Ohta M, Iwaki T, Kitamoto T, Takeshita I, Tateishi J, Fukui M (1994) MIB1 staining index and scoring of histologic features in meningioma. Indicators for the prediction of biologic potential and postoperative management. Cancer 74:3176–3189

    CAS  PubMed  Google Scholar 

  25. Perry A, Chicoine MR, Filiput E, Miller JP, Cross DT (2001) Clinicopathologic assessment and grading of embolized meningiomas: a correlative study of 64 patients. Cancer 92:701–711

    Article  CAS  PubMed  Google Scholar 

  26. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1998) The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 82:2262–2269

    Article  CAS  PubMed  Google Scholar 

  27. Philippon J, Cornu P, Grob R, Rivierez M (1986) Les mèningiomes récidivantes. Neurochirurgie 32:54–62

    Google Scholar 

  28. Remmele W, Stegner HE (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8:138–140

    CAS  PubMed  Google Scholar 

  29. Roser F, Nakamura M, Bellinzona M, Rosahl SK, Ostertag H, Samii M (2004) The prognostic value of progesterone receptor status in meningiomas. J Clin Pathol 57:1033–1037

    Article  CAS  PubMed  Google Scholar 

  30. Roser F, Samii M, Ostertag H, Bellinzona M (2004) The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases. Acta Neurochir (Wien) 146:37–44

    Article  CAS  Google Scholar 

  31. Roux FX, Nataf F, Pinaudeau M, Borne G, Devaux B, Meder JF (1996) Intraspinal meningiomas: review of 54 cases with discussion of poor prognosis factors and modern therapeutic management. Surg Neurol 46:458–463

    Article  CAS  PubMed  Google Scholar 

  32. Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22–39

    Article  CAS  PubMed  Google Scholar 

  33. Solero CL, Fornari M, Giombini S, Lasio G, Oliveri G, Cimino C, Pluchino F (1989) Spinal meningiomas: review of 174 operated cases. Neurosurgery 25:153–160

    Article  CAS  PubMed  Google Scholar 

  34. Stechison MT, Tasker RR, Wortzman G (1987) Spinal meningioma en plaque Report of two cases. J Neurosurg 67:452–455

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, University of Tübingen, Hoppe-Seyler-Str.3, 72076, Tuebingen, Germany

    Florian Roser, Rainer Ritz & Marcos S. Tatagiba

  2. Department of Neurosurgery, Klinikum Hannover Nordstadt, Hannover, Germany

    Florian Roser, Florian Roser, Makoto Nakamura & Mattia Bellinzona

  3. Department of Pathology, Klinikum Hannover Nordstadt, Hannover, Germany

    Helmut Ostertag

Authors
  1. Florian Roser
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Makoto Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mattia Bellinzona
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rainer Ritz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Helmut Ostertag
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Marcos S. Tatagiba
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Florian Roser.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roser, F., Nakamura, M., Bellinzona, M. et al. Proliferation potential of spinal meningiomas. Eur Spine J 15, 211–215 (2006). https://doi.org/10.1007/s00586-005-0937-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00586-005-0937-z

Keywords

Search

Navigation